Bhubaneswar: Chief Minister Mohan Charan Majhi on Tuesday asserted that Odisha will soon be a leading destination for pharmaceutical and medical device investments – the most competitive hub for innovation and jobs.
Majhi said this while addressing the Odisha Pharma Summit 2025, the state’s first dedicated summit focused on pharmaceuticals, medical devices, and life sciences manufacturing. The summit was organised by the government of Odisha in association with FICCI in Bhubaneswar.
The landmark event marked a significant milestone in Odisha’s industrial diversification journey, bringing together industry leaders, global manufacturers, Med Tech innovators, researchers, investors, and policymakers on a single platform. Odisha Pharma Summit 2025 showcased the state’s growing strengths in Pharmaceuticals, Medical devices manufacturing, progressive policy framework, infrastructure readiness, and skilled manpower, positioning Odisha as an emerging destination in India’s Pharmaceuticals & Medical Devices value chain.
The summit witnessed strong investor response, with a total of 45 Memoranda of Understanding (MoUs) signed across pharmaceuticals, medical technologies, and industrial infrastructure. These MoUs represent an investment commitment of Rs 6,263 crore, with an estimated employment generation potential of 38,406 jobs, reinforcing Odisha’s focus on inclusive, employment-intensive, and sustainable industrial growth.
Key Highlights:
• For Pharmaceuticals: 32 MoUs with proposed investments of Rs 2,681 crore, generating over 6,528 employment opportunities.
• For Medical Technology & Devices: 12 MoUs with Rs 582 crore in committed investments, creating over 1,878 jobs.
• For a Landmark Industrial Park Proposal: 1 MoU with an investment of ₹3,000 crore, expected to generate nearly 30,000 jobs.
• Investment Intent of : Rs 780 cr and employment potential of 6240 received during the event
The summit witnessed the participation of over 300 organisations and more than 400 delegates, representing the entire life sciences value chain including APIs, bulk drugs, formulations, vaccines, diagnostics, medical devices, healthcare services, research institutions, skilling partners, industry associations and Students.
Leading industry players such as Infunex, Aurobindo Pharma, Granules Lifesciences, Macleods Pharmaceuticals, Biological E. Ltd , Pharmexcil, Vaccines and Cipla, among others, actively engaged in sectoral discussions, investment deliberations, and one-to-one meetings, expl
oring strategic growth opportunities in Odisha.
Senior officials from the state government were also present at the summit, reflecting the state’s whole-of-government approach to investor facilitation and sectoral development. The discussions reaffirmed Odisha’s steadfast commitment to ease of doing business, responsive governance, coordinated decision-making, and seamless investor support.
The key highlight of the summit was the launch of the Odisha Pharmaceutical and Medical Devices Policy 2025, a forward-looking policy aimed at building a globally competitive, innovation-led, and employment-oriented life sciences ecosystem in the State. The policy offers a comprehensive framework covering infrastructure development, investment facilitation, research and development, skill development, and targeted incentives for pharmaceuticals and medical devices manufacturing.
The Chief Minister also unveiled two new industrial parks one dedicated to pharmaceuticals Park at Khordha-Nayagarh and the second to Medical Devices Manufacturing Park at Khordha. These parks are equipped with industrial infrastructure, common utilities, testing and certification facilities, and compliance-ready ecosystems to enable faster project implementation and ease of operations.
“Odisha is ready to emerge as a leading hub for pharmaceuticals and medical devices in India. With our new Odisha Pharmaceutical and Medical Devices Policy 2025 and pharma parks, we offer one of the country’s most competitive ecosystems for investment, innovation and jobs. I invite industry leaders to come, invest in Odisha and join us in this transformative journey yahi samay hai, sahi samay hai.” Chief Minister Majhi said. He emphasised that Odisha’s strategic coastal location, port-led connectivity, and transparent governance framework make it uniquely positioned to attract global pharmaceutical and Medical Devices Manufacturing investments.
Industries, Skill Development & Technical Education Minister Sampad Chandra Swain, stated: “The Odisha Pharma Summit 2025 reflects our State’s sector-focused industrialisation strategy. With progressive policies, dedicated industrial parks, skilled manpower, and proactive governance, Odisha offers a compelling value proposition for pharmaceutical and medical device manufacturers.”
The success of the Summit 2025 marks a significant step in the State’s journey to become a leading hub for pharmaceutical and medical devices manufacturing in India. With strong policy support, modern infrastructure, and committed leadership, Odisha is shaping a future-ready ecosystem that inspires investor confidence.
Following the summit, the Chief Minister and a delegation from the state government will visit Hyderabad for roadshow on December 19, reinforcing the State’s roadmap towards Samruddha Odisha by 2036. Building on this momentum, Odisha is steadily emerging as one of the most attractive investment destinations in the country.